Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of GW597599 and GR205171 on sleep and daytime function in adults with primary insomnia
2007-004035-35Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Insomnia comparing GW597599 sequence, GR205171 sequence and Placebo sequence (3 arms). Primary endpoints: Total Sleep Time (TST), Latency to Persistent Sleep (LPS) and 1 more. Started Sep 2007; status: completed.
02
Drugs
vestipitantvofopitant
03
Conditions
Insomnia
Beyond the preview
Go deeper on 2007-004035-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004035-35.